Release of LPL activity after intravenous injection of a low molecular weight heparin.

Por Etienne, J, Millot, F, Pieron, R, Laruelle, P
Publicado em 1983

In vitro evaluation of a new injectable calcium phosphate material

Por Grimandi, Gaël, Weiss, Pierre, Millot, F., Daculsi, Guy
Publicado no J Biomed Mater Res (1998)

Unresectable localized neuroblastoma: improved survival after primary chemotherapy including carboplatin-etoposide. Neuroblastoma Study Group of the Société Française d'Oncologi...

Por Rubie, H., Michon, J., Plantaz, D., Peyroulet, M. C., Coze, C., Frappaz, D., Chastagner, P., Baranzelli, M. C., Méchinaud, F., Boutard, P., Lutz, P., Perel, Y., Leverger, G., de Lumley, L., Millot, F., Stéphan, J. L., Margueritte, G., Hartmann, O.
Publicado em 1998

Infectious diseases in the first year of life, perinatal characteristics and childhood acute leukaemia

Por Jourdan-Da Silva, N, Perel, Y, Méchinaud, F, Plouvier, E, Gandemer, V, Lutz, P, Vannier, J P, Lamagnére, J L, Margueritte, G, Boutard, P, Robert, A, Armari, C, Munzer, M, Millot, F, de Lumley, L, Berthou, C, Rialland, X, Pautard, B, Hémon, D, Clavel, J
Publicado em 2004

Adverse outcome of infants with metastatic neuroblastoma, MYCN amplification and/or bone lesions: results of the French Society of Pediatric Oncology

Por Minard, V, Hartmann, O, Peyroulet, M C, Michon, J, Coze, C, Defachelle, A S, Lejars, O, Perel, Y, Bergeron, C, Boutard, P, Leverger, G, Stephan, J L, Thyss, A, Chastagner, P, Couillault, G, Devalck, C, Lutz, P, Mechinaud, F, Millot, F, Plantaz, D, Rialland, X, Rubie, H
Publicado em 2000